A new class of nucleoside analogues were synthesized using cyclic dipeptides and modified 2'-deoxyfuranoribose sugars to introduce flexibility by peptides in place of common nucleoside bases and to determine their biological properties. The synthesis was carried out by coupling of a protected ribose sugar with synthesized dipeptides in the presence of hexamethyldisilazane and trimethylsilyltriflate. The final products were characterized by NMR and high resolution MS-TOF spectroscopy. The compounds were evaluated for anti-HIV activities. 1-(4-Azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6-diisopropylpiperazine-2,5-dione (compound 14) containing 3-and 6-isopropyl groups in the base and 3'-azide (EC50 = 1.96 µM) was the most potent compound among all the synthesized analogs.
Introduction
Nucleoside drugs are modified analogues of naturally occurring nucleosides, pyrimidines and purines [1] [2] [3] that have found wide applications in anti-cancer and anti-HIV therapy. [4] [5] [6] [7] As an example, cytarabine (ara-C, Figure 1 ) is a pyrimidine analogue containing an arabinose sugar and has been used in the treatment of different cancers, such as acute myelogenous leukemia (AML) and non-Hodgkin's lymphoma (NHL), chronic myelocytic leukemia (blast phase), acute lymphoblastic leukemia(ALL) and erythroleukemia. [8] [9] Other modified pyrimidine analogues drugs such as lamivudine (2′,3′-dideoxy-3′-thiacytidine,3TC) and emtricitabine (5-fluoro-2′,3′-dideoxy-3′-thiacytidine, FTC) ( Figure 1 ) have also found extensive use in anti-HIV therapy. [10] [11] The modified nucleoside analogues have been designed to introduce functional groups or alterations in either sugar, base, or both parts. 12 For example, zidovudine (AZT) (Figure 1 ), a modified thymidine analogue commonly used in anti-HIV therapy, has an azide (-N3) in place of 3-hydroxyl (-OH) group of thymidine sugar. 4 Similarly, 3TC and FTC derivatives have sulfur at 3-position of sugar while FTC also has a fluorine at C5 position of the base. 13 Mechanism of activity of modified nucleoside generally involves binding on growing DNA/RNA, inhibition of DNA/RNA synthesis by chain termination, and/or interacting with enzymes in the process. 14 Herein, we report the synthesis of a new class of modified nucleosides by introducing a cyclic-dipeptide [15] [16] at the C-1 position of 2'-deoxyfuranoribose . The cyclic dipeptides containing two amide groups were designed as a six membered ring similar to a pyrimidine base. The double bond of the pyrimidine base 17 was removed to generate more flexibility in the base structure.
Results and Discussion
Three commercial available cyclic dipeptides, 18 diketopiperazine, dimethyldiketopiperazine, and diisopropyldiketopiperazine were used as building blocks for conjugation with protected carbohydrates. The protected 2'-deoxyfuranoribose methoxide or halides were synthesized according to the previously reported procedures. 19 The ditoluoyl2'-deoxyfuranoribose chloride (1) was synthesized by protection of 2'-deoxyfuranoribosemethoxide followed by chlorination with dry HCl. The benzyloyl protected azido-2′-deoxyribosemethoxide(2) was synthesized from D-xylose (Supporting information).
Scheme 1. Chemical synthesis of 2'-deoxyribofuranosylcyclodipeptides.
Previous reports have shown that cyclodipeptide can react with alkyl halides using various mild to strong bases. [20] [21] Similar coupling/substitution reactions were used with protected sugar chloride using different bases viz. sodium hydride (NaH), 1,8-diazabicyclo [5.4 .0]undec-7-ene(DBU), 22 butyl lithium, sodium methoxide, sodium hydroxide, and potassium hydroxide, but these methods were unsuccessful for the synthesis of desired products. In most of the cases, degraded sticky mixture of undesired products was obtained. In the case of reaction performed using NaH showed the presence of a negligible amount of desired product along with a number of different undesired products as shown by mass spectrometry of crude reaction mixture but we were unable to isolate the product. The reaction performed using DBU as a base led to conjugation of DBU to sugar (DBU-sugar product) instead of formation of desired peptide-sugar product (data not shown).
Alternatively, the cyclodipeptide was reacted with hexamethyldisilane 23 in dioxane with refluxing to form bis-trimethanesilanyl cyclopeptide, which was subsequently coupled with carbohydrate chloride (1) and carbohydrate methoxide (2). [24] [25] Subsequent complex was cleaved/deprotected using trimethylsilyl(TMS)-triflate to the desired protected carbohydrate-cyclopeptide products (3-8) in a mixture of -isomers.
Finally, the sugar protecting groups (toluolyl or benzoyl) were removed in the presence of methanolic ammonia solution (7% w/v) to generate 2′-deoxyribofuranosecyclodipeptide products 9-14. The final products were purified by HPLC using the protocol described in the experimental section. The final product was identified by 1D, 2D NMR spectroscopy and high resolution MS-TOF spectroscopy.
All the synthesized compounds were evaluated for their inhibitory activity of HIV-1 (subtype B, US/92/727) replication in human peripheral blood mononuclear (PBMC) cells. 26 Table 1 illustrates the anti-HIV-1 activity (EC50) and cytotoxicity (TC50) of the nucleoside ester conjugates compared with AZT. No cytotoxicity was observed up to the highest tested concentration for the synthesized conjugates 9-14 (TC50100 µM) (1-7). (detailed activity in supporting information).
Conclusions
In conclusion, novel six 2'-deoxyribofuranosyl cyclodipeptides were synthesized and characterized by using NMR and mass spectroscopy. The synthesized derivatives were evaluated for their anti-HIV activity. The compounds exhibited inferior anti-HIV activity than AZT. The data indicate that the loss of planarity (aromaticity) of base moiety in the structures is detrimental in biological activity of these compounds. On the other hand, incorporation of more lipophilic alkyl groups at positions 3 and 6 of the base in 3′-azido analogs generated compounds with modest anti-HIV activity.
Experimental Protocols
Materials and methods. Cyclodipeptides were purchased from Chem-Impex
International, Wood dale, IL, USA. Anhydrous solvents and other chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI). The chemical structures of final products were characterized by nuclear magnetic resonance spectra
( 1 H NMR, 13 C NMR) obtained on a Bruker NMR spectrometer (400 MHz) or a Varian NMR spectrometer (500 MHz). 13 C NMR spectra are fully decoupled. Chemical shifts were reported in parts per millions (ppm) using deuterated solvent peak or tetramethylsilane 
1-(4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-piperazine-2,5-dione (9).
Compound 3 (10 mg, 0.02 mmol) was stirred with methanolic ammonium solution (7%, 10 mL) at room temperature for 30 min. The solvent was evaporated under reduced pressure, and the crude product was purified on flash chromatography using CHCl3/methanol (0-100%, v/v) eluent. The product was further purified on a reverse phase HPLC using water:methanol eluents (3 mg, 62% yield). 1 
5-(2,5-Dimethyl-3,6-dioxopiperazin-1-yl)-2-(((4-methylbenzoyl)oxy)methyl) tetrahydrofuran-3-yl 4-methylbenzoate (4)
.
1-(4-Azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-piperazine-2,5-dione (12).
Compound 4(7 mg, 0.019 mmol) was hydrolyzed with methanolic ammonia solution (3 mL of 7% sol) and purified by flash chromatography and reverse phase HPLC (yield 2.6 mg, 52% Anti-HIV-1 Evaluation in PMBC Assay. PBMC based anti-HIV assays were performed as previously described. 26 Briefly, PHA-stimulated PBMCs cultured in the presence of IL-2 were suspended at 1 × 10 6 cells/mL and were added to a 96-well round-bottom plate. Serially diluted test materials were added to the plate in triplicate followed by the appropriate pre-titered strain of HIV. The culture was incubated for 7 days at 37 °C/5%
CO2. Following the incubation, supernatants were collected for analysis of virus replication by supernatant RT activity and cells analyzed for viability by XTT dye reduction. AZT was used as an internal assay standard. All the assays were carried out in triplicate.
